December 2013 Life Science Industry Research Reports

Ulcers – Pipeline Review, H2 2013

Published in Dec 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Ulcers Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also […]

Traveler’s Diarrhea – Pipeline Review, H2 2013

Published in Dec 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Traveler’s Diarrhea Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Traveler’s Diarrhea, complete with latest updates, and special features on late-stage and discontinued projects. […]

Spinocerebellar Ataxias – Pipeline Review, H2 2013

Published in Dec 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Spinocerebellar Ataxias Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Spinocerebellar Ataxias, complete with latest updates, and special features on late-stage and discontinued projects. […]

Neisseria Meningitidis Infections – Pipeline Review, H2 2013

Published in Dec 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Neisseria Meningitidis Infections Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Neisseria Meningitidis Infections, complete with latest updates, and special features on late-stage and […]

Retinal Degeneration – Pipeline Review, H2 2013

Published in Dec 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Retinal Degeneration Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Retinal Degeneration, complete with latest updates, and special features on late-stage and discontinued projects. […]

Progressive Supranuclear Palsy – Pipeline Review, H2 2013

Published in Dec 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Progressive Supranuclear Palsy Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Progressive Supranuclear Palsy, complete with latest updates, and special features on late-stage and […]

Arterial Thrombosis – Pipeline Review, H2 2013

Published in Dec 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Arterial Thrombosis Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Arterial Thrombosis, complete with latest updates, and special features on late-stage and discontinued projects. […]

Peripheral Neuropathic Pain – Pipeline Review, H2 2013

Published in Dec 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Peripheral Neuropathic Pain Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Peripheral Neuropathic Pain, complete with latest updates, and special features on late-stage and […]

Periodontitis – Pipeline Review, H2 2013

Published in Dec 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Periodontitis Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Periodontitis, complete with latest updates, and special features on late-stage and discontinued projects. It also […]

Adrenocortical Carcinoma (Adrenal Cortex Cancer) – Pipeline Review, H2 2013

Published in Dec 2013 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Adrenocortical Carcinoma (Adrenal Cortex Cancer) Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Adrenocortical Carcinoma (Adrenal Cortex Cancer), complete with latest updates, and special […]